Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 235

Sort by

Sort Order Select

Journal Articles

Adiponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes

Sarah Fawaz, Aldara Martin Alonso, Yan Qiu, Raina Ramnath, Holly Stowell-Connolly, Monica Gamez, Carl May, Colin Down, Richard J. Coward, Matthew J. Butler, Gavin I. Welsh, Simon C. Satchell, Rebecca R. Foster

Diabetes 2024;73(6):964–976

https://doi.org/10.2337/db23-0455

Published: 26 March 2024

View article titled, Adiponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes

Journal Articles

Adipose Signals Regulating Distal Organ Health and Disease

Ankit Gilani, Lisa Stoll, Edwin A. Homan, James C. Lo

Diabetes 2024;73(2):169–177

https://doi.org/10.2337/dbi23-0005

Published: 19 January 2024

View article titled, Adipose Signals Regulating Distal Organ Health and Disease

Meeting Abstracts

844-P: Lanifibranor Improves Markers of Cardiometabolic Health in Patients with NASH and Type 2 Diabetes, Correlated with Responses in Adiponectin Levels

LOUIS H. GRIFFEL, SVEN FRANCQUE, MANAL F. ABDELMALEK, PHILIPPE HUOT-MARCHAND, LUCILE DZEN, MARTINE BAUDIN, JEAN L. JUNIEN, PIERRE BROQUA, MICHAEL P. COOREMAN

Diabetes 2023;72(Supplement_1):844-P

https://doi.org/10.2337/db23-844-P

Published: 20 June 2023

View article titled, 844-P: Lanifibranor Improves Markers of Cardiometabolic Health in Patients with NASH and Type 2 Diabetes, Correlated with Responses in Adiponectin Levels

Journal Articles

Vertical Sleeve Gastrectomy Lowers SGLT2/Slc5a2 Expression in the Mouse Kidney

Elina Akalestou, Livia Lopez-Noriega, Iain R. Tough, Ming Hu, Isabelle Leclerc, Helen M. Cox, Guy A. Rutter

Diabetes 2022;71(8):1623–1635

https://doi.org/10.2337/db21-0768

Published: 21 August 2022

View article titled, Vertical Sleeve Gastrectomy Lowers SGLT2/<em>Slc5a2</em> Expression in the Mouse Kidney

Meeting Abstracts

803-P: Serum Adiponectin Level Is Reduced after Short-Term Intensive Insulin Therapy in Patients with Newly Diagnosed Type 2 Diabetes

LIEHUA LIU, WEIJIAN KE, JIE CHEN, YANBING LI

Diabetes 2022;71(Supplement_1):803-P

https://doi.org/10.2337/db22-803-P

Published: 01 June 2022

View article titled, 803-P: Serum Adiponectin Level Is Reduced after Short-Term Intensive Insulin Therapy in Patients with Newly Diagnosed Type 2 Diabetes

Meeting Abstracts

1382-P: Novel Mechanisms to Reconvert Glucocorticoids into Pro-Metabolic Agents through Adiponectin

MICHELLE WINTZINGER, KAREN MIZ, MANOJ PANTA, HIMA BINDU DURUMUTLA, ASHOK DANIEL PRABAKARAN PRAGASAM, MATTIA QUATTROCELLI

Diabetes 2022;71(Supplement_1):1382-P

https://doi.org/10.2337/db22-1382-P

Published: 01 June 2022

View article titled, 1382-P: Novel Mechanisms to Reconvert Glucocorticoids into Pro-Metabolic Agents through Adiponectin

Meeting Abstracts

1051-P: Elevated Cord Serum Adiponectin Concentration Is Associated with Increased Risk for Fetal Overgrowth

XINHUA CHEN, JOSHUA A. WHITING

Diabetes 2022;71(Supplement_1):1051-P

https://doi.org/10.2337/db22-1051-P

Published: 01 June 2022

View article titled, 1051-P: Elevated Cord Serum Adiponectin Concentration Is Associated with Increased Risk for Fetal Overgrowth

Meeting Abstracts

1249-P: How Can Serum Adiponectin Levels Be Evaluated in Clinical Settings?

SHOMA ONO, MAKOTO DAIMON, AYA KAMBA, SATORU MIZUSHIRI, MASAYA MURABAYASHI, YUKI NISHIYA, RYOMA ITO, AYUMI TAMURA

Diabetes 2022;71(Supplement_1):1249-P

https://doi.org/10.2337/db22-1249-P

Published: 01 June 2022

View article titled, 1249-P: How Can Serum Adiponectin Levels Be Evaluated in Clinical Settings?

Meeting Abstracts

1118-P: Prediction of Clamp-Derived Insulin Sensitivity in African Americans from Clinical Risk Factors

LAUREN A. FOWLER, VIBHU PARCHA, CATHARINE COUCH, W. TIMOTHY GARVEY, BARBARA GOWER

Diabetes 2022;71(Supplement_1):1118-P

https://doi.org/10.2337/db22-1118-P

Published: 01 June 2022

View article titled, 1118-P: Prediction of Clamp-Derived Insulin Sensitivity in African Americans from Clinical Risk Factors

Journal Articles

Low Plasma Adiponectin in Risk of Type 2 Diabetes: Observational Analysis and One- and Two-Sample Mendelian Randomization Analyses in 756,219 Individuals

Maria B. Nielsen, Yunus Çolak, Marianne Benn, Børge G. Nordestgaard

Diabetes 2021;70(11):2694–2705

https://doi.org/10.2337/db21-0131

Published: 23 August 2021

View article titled, Low Plasma Adiponectin in Risk of Type 2 Diabetes: Observational Analysis and One- and Two-Sample Mendelian Randomization Analyses in 756,219 Individuals

Meeting Abstracts

757-P: Cardiometabolic Disease Risk Assessment of HIV Medication Regimens

ADRIAN ELZARKI, SESHAGIRI RAO NANDULA, HASSAN AWAL, SABYASACHI SEN

Diabetes 2021;70(Supplement_1):757-P

https://doi.org/10.2337/db21-757-P

Published: 01 June 2021

View article titled, 757-P: Cardiometabolic Disease Risk Assessment of HIV Medication Regimens

Meeting Abstracts

1194-P: Promotive Effects of Recombinant Human Adiponectin on Bone Regeneration by Paracrine

YANPING GONG

Diabetes 2021;70(Supplement_1):1194-P

https://doi.org/10.2337/db21-1194-P

Published: 01 June 2021

View article titled, 1194-P: Promotive Effects of Recombinant Human Adiponectin on Bone Regeneration by Paracrine

Meeting Abstracts

119-LB: Increased Adiponectin following Efruxifermin Treatment Is Associated with Improvements in Dyslipidemia, Glucose Metabolism, and Liver Health in a 16-Week, Randomized, Placebo-Controlled NASH Trial

JUAN PABLO FRIAS, ERIK J. TILLMAN, RESHMA SHRINGARPURE, ERICA FONG, BRITTANY DE TEMPLE, TIMOTHY ROLPH, ANDREW CHENG, KITTY YALE, STEPHEN A. HARRISON

Diabetes 2021;70(Supplement_1):119-LB

https://doi.org/10.2337/db21-119-LB

Published: 01 June 2021

View article titled, 119-LB: Increased Adiponectin following Efruxifermin Treatment Is Associated with Improvements in Dyslipidemia, Glucose Metabolism, and Liver Health in a 16-Week, Randomized, Placebo-Controlled NASH Trial

Meeting Abstracts

120-OR: Dapagliflozin Increases Adiponectin and Its Receptors, and Reduces Inflammation and Ceramide Synthesis Enzymes in the Obese Prediabetic Dog

MORVARID KABIR, RICHARD N. BERGMAN, V. SASHI GOPAUL, HSIUCHIUNG YANG, CATHRYN M. KOLKA

Diabetes 2021;70(Supplement_1):120-OR

https://doi.org/10.2337/db21-120-OR

Published: 01 June 2021

View article titled, 120-OR: Dapagliflozin Increases Adiponectin and Its Receptors, and Reduces Inflammation and Ceramide Synthesis Enzymes in the Obese Prediabetic Dog

Meeting Abstracts

1081-P: Serum Total Adiponectin Level Is Associated with Onset of Diabetes in Male Japanese: Tokushima Cohort Study

AKIKO HATA, MASASHI MIYOSHI, TAKAYUKI NAKAO, TAKAKO ICHIHARA, AYAKO TAMURA, TAKAKO MINAGAWA, YUMI KUWAMURA, MAKOTO FUNAKI

Diabetes 2021;70(Supplement_1):1081-P

https://doi.org/10.2337/db21-1081-P

Published: 01 June 2021

View article titled, 1081-P: Serum Total Adiponectin Level Is Associated with Onset of Diabetes in Male Japanese: Tokushima Cohort Study

Meeting Abstracts

152-LB: Homeostatic Model Assessment of Adiponectin (HOMA-AD) in Youth across the Spectrum of Adiposity and along the Span of Glycemia

JORDAN JACOB, JOON YOUNG KIM, SILVA A. ARSLANIAN

Diabetes 2021;70(Supplement_1):152-LB

https://doi.org/10.2337/db21-152-LB

Published: 01 June 2021

View article titled, 152-LB: Homeostatic Model Assessment of Adiponectin (HOMA-AD) in Youth across the Spectrum of Adiposity and along the Span of Glycemia

Meeting Abstracts

179-LB: Association of Leptin and Adiponectin with the Incidence of Type 2 Diabetes Independent of Visceral Adiposity and Liver Fat

IZUMI SHIBATA, MIKIKO SHIBATA, KYOKO K. SATO, SHINICHIRO UEHARA, NORIMITSU NISHIDA, KAORI OKAMURA, YOSHIHIKO YUYAMA, HIDEO KOH, YONEZO HIKITA, WILFRED Y. FUJIMOTO, EDWARD J. BOYKO, TOMOSHIGE HAYASHI

Diabetes 2021;70(Supplement_1):179-LB

https://doi.org/10.2337/db21-179-LB

Published: 01 June 2021

View article titled, 179-LB: Association of Leptin and Adiponectin with the Incidence of Type 2 Diabetes Independent of Visceral Adiposity and Liver Fat

Meeting Abstracts

333-OR: Regulation of Adiponectin Receptor 2 Expression and Function in the Liver

JASON HADLEY, DARAH A. SCRUGGS, JIYOON RYU, LILY Q. DONG

Diabetes 2021;70(Supplement_1):333-OR

https://doi.org/10.2337/db21-333-OR

Published: 01 June 2021

View article titled, 333-OR: Regulation of Adiponectin Receptor 2 Expression and Function in the Liver

Journal Articles

Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration

Jiyoon Ryu, Jason T. Hadley, Zhi Li, Feng Dong, Huan Xu, Xiaoban Xin, Ye Zhang, Cang Chen, Senlin Li, Xiaoning Guo, Jared L. Zhao, Robin J. Leach, Muhammad A. Abdul-Ghani, Ralph A. DeFronzo, Amrita Kamat, Feng Liu, Lily Q. Dong

Diabetes 2021;70(6):1303–1316

https://doi.org/10.2337/db20-1073

Published: 18 March 2021

View article titled, Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration

Journal Articles

A Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive β-Cell Hyperplasia

Christine M. Kusminski, Alexandra L. Ghaben, Thomas S. Morley, Ricardo J. Samms, Andrew C. Adams, Yu An, Joshua A. Johnson, Nolwenn Joffin, Toshiharu Onodera, Clair Crewe, William L. Holland, Ruth Gordillo, Philipp E. Scherer

Diabetes 2020;69(3):313–330

https://doi.org/10.2337/db19-0327

Published: 27 December 2020

View article titled, A Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive β-Cell Hyperplasia

Includes: Supplementary data

NARROW

Adiponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes

Adipose Signals Regulating Distal Organ Health and Disease

844-P: Lanifibranor Improves Markers of Cardiometabolic Health in Patients with NASH and Type 2 Diabetes, Correlated with Responses in Adiponectin Levels

Vertical Sleeve Gastrectomy Lowers SGLT2/Slc5a2 Expression in the Mouse Kidney

803-P: Serum Adiponectin Level Is Reduced after Short-Term Intensive Insulin Therapy in Patients with Newly Diagnosed Type 2 Diabetes

1382-P: Novel Mechanisms to Reconvert Glucocorticoids into Pro-Metabolic Agents through Adiponectin

1051-P: Elevated Cord Serum Adiponectin Concentration Is Associated with Increased Risk for Fetal Overgrowth

1249-P: How Can Serum Adiponectin Levels Be Evaluated in Clinical Settings?

1118-P: Prediction of Clamp-Derived Insulin Sensitivity in African Americans from Clinical Risk Factors

Low Plasma Adiponectin in Risk of Type 2 Diabetes: Observational Analysis and One- and Two-Sample Mendelian Randomization Analyses in 756,219 Individuals

757-P: Cardiometabolic Disease Risk Assessment of HIV Medication Regimens

1194-P: Promotive Effects of Recombinant Human Adiponectin on Bone Regeneration by Paracrine

119-LB: Increased Adiponectin following Efruxifermin Treatment Is Associated with Improvements in Dyslipidemia, Glucose Metabolism, and Liver Health in a 16-Week, Randomized, Placebo-Controlled NASH Trial

120-OR: Dapagliflozin Increases Adiponectin and Its Receptors, and Reduces Inflammation and Ceramide Synthesis Enzymes in the Obese Prediabetic Dog

1081-P: Serum Total Adiponectin Level Is Associated with Onset of Diabetes in Male Japanese: Tokushima Cohort Study

152-LB: Homeostatic Model Assessment of Adiponectin (HOMA-AD) in Youth across the Spectrum of Adiposity and along the Span of Glycemia

179-LB: Association of Leptin and Adiponectin with the Incidence of Type 2 Diabetes Independent of Visceral Adiposity and Liver Fat

333-OR: Regulation of Adiponectin Receptor 2 Expression and Function in the Liver

Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration

A Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive β-Cell Hyperplasia

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only